In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas.

Stay updated with what’s happening on the hill by visiting aan.com/chr.

Learn how you can get involved with AAN advocacy.

Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.

Show reference:

https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

In the final installment of this three-part series, Dr. Elizabeth Zollos discusses another important diagnostic tool, visually evoked potentials or VEP.

Dr. Halley Alexander and Dr. Samuel W. Terman discuss patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques.

Show reference:

https://www.neurology.org/doi/10.1212/CPJ.0000000000200475

Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000213638

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper.

Show reference:

https://www.neurology.org/doi/10.1212/NXI.0000000000200397

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss how patients with amyloid-beta–related angiitis present.

Show reference:

https://www.neurology.org/doi/10.1212/NXI.0000000000200397

In the concluding segment of this series, Dr. Halley Alexander and Dr. Coral M. Stredny delve into the essential components of seizure action plans and identify the individuals who should have one.

Show reference:

https://www.neurology.org/doi/10.1212/CPJ.0000000000200449